Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
Clinical trial NCT05425446 · COMPLETED
Trial details
- NCT number
- NCT05425446
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2024-08-09
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.